As of 2024-12-13, the Intrinsic Value of Thermo Fisher Scientific Inc (TMO) is
677.87 USD. This TMO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 525.00 USD, the upside of Thermo Fisher Scientific Inc is
29.10%.
The range of the Intrinsic Value is 411.51 - 1,695.11 USD
677.87 USD
Intrinsic Value
TMO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
411.51 - 1,695.11 |
677.87 |
29.1% |
| DCF (Growth 10y) |
601.69 - 2,283.46 |
952.64 |
81.5% |
| DCF (EBITDA 5y) |
660.61 - 770.88 |
710.04 |
35.2% |
| DCF (EBITDA 10y) |
868.75 - 1,103.66 |
974.51 |
85.6% |
| Fair Value |
306.85 - 306.85 |
306.85 |
-41.55% |
| P/E |
478.13 - 591.40 |
545.76 |
4.0% |
| EV/EBITDA |
496.26 - 571.79 |
538.89 |
2.6% |
| EPV |
191.70 - 286.44 |
239.07 |
-54.5% |
| DDM - Stable |
173.55 - 719.20 |
446.37 |
-15.0% |
| DDM - Multi |
362.99 - 1,163.00 |
552.51 |
5.2% |
TMO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
200,812.50 |
| Beta |
0.53 |
| Outstanding shares (mil) |
382.50 |
| Enterprise Value (mil) |
231,480.50 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.24% |
| Cost of Debt |
4.67% |
| WACC |
7.65% |